Sugi Predict

Sugi Predict / Targets / UBQLN1

UBQLN1

Ubiquilin-1 · Q9UMX0 · UBQLN1 on Sugi Atlas →

0 patent compounds predicted against UBQLN1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UBQLN1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Colchicine for Amyotrophic Lateral Sclerosis PHASE2COMPLETED
Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome PHASE1RECRUITING
Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS) nanUNKNOWN
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
A Natural History Study of Angelman Syndrome nanRECRUITING
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Stakeholders of Rare Diseases Informing Values In Neuroethics nanRECRUITING
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study nanRECRUITING
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Identification of New FTLD Genes nanUNKNOWN
Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study nanUNKNOWN
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Characterization of Angelman Syndrome nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Genetic Analysis to Predict the Development of Paget's Disease nanACTIVE_NOT_RECRUITING
Gene Analysis of Parkinson's Disease nanCOMPLETED
Genetics of Familial and Sporadic ALS nanCOMPLETED
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
Phenotype/Genotype Correlations in Neuromuscular Disorders nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
Study of Proteus Syndrome and Related Congenital Disorders nanRECRUITING
Answer ALS: Individualized Initiative for ALS Discovery nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a UBQLN1 binder may also engage these)

ProteinNameSimilarity
Q5R684 — 1.000 Q5R684 →
Q8R317 — 1.000 Q8R317 →
Q9JJP9 — 1.000 Q9JJP9 →
Q99NB8 — 1.000 Q99NB8 →
Q9SII9 — 0.997 Q9SII9 →
Q9NRR5 — 0.996 Q9NRR5 →
Q9QZM0 — 0.996 Q9QZM0 →
Q9SII8 — 0.995 Q9SII8 →
UBQLN2 Ubiquilin-2 0.993 landscape →
G5EFF7 — 0.977 G5EFF7 →
Q9NIF3 — 0.976 Q9NIF3 →
Q84L31 — 0.971 Q84L31 →
A3KMV2 — 0.971 A3KMV2 →
Q84L32 — 0.971 Q84L32 →
Q10169 — 0.970 Q10169 →
P48510 — 0.969 P48510 →
P54725 — 0.968 P54725 →
Q84L30 — 0.966 Q84L30 →
Q84L33 — 0.965 Q84L33 →
Q98SH3 — 0.963 Q98SH3 →
P54726 — 0.963 P54726 →
Q40742 — 0.962 Q40742 →
Q6NZ09 — 0.962 Q6NZ09 →
Q6GN67 — 0.961 Q6GN67 →
Q29RK4 — 0.961 Q29RK4 →
Q6NYI0 — 0.958 Q6NYI0 →
Q9JMB5 — 0.958 Q9JMB5 →
A1L5A6 — 0.958 A1L5A6 →
RAD23B UV excision repair protein RAD23 homolog B 0.957 landscape →
Q9JKV1 — 0.956 Q9JKV1 →